Evaluation of a new screen agar plate for detection and presumptive identification of Enterobacteriaceae producing extended-spectrum β-lactamases

Diagnostic Microbiology and Infectious Disease

Volumn 51, Issue 1, 2005, Pages 51-55

  Stürenburg, Enno ^a   Sobottka, Ingo ^a   Laufs, Rainer ^a   Mack, Dietrich ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Agar screen plate; Antimicrobial susceptibility testing; Extended spectrum lactamase detection

Indexed keywords

AGAR; BETA LACTAMASE;

ARTICLE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; COLONY FORMING UNIT; CONCENTRATION (PARAMETERS); ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; FECES ANALYSIS; INOCULATION; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEUS MIRABILIS; SENSITIVITY AND SPECIFICITY;

AGAR; BETA-LACTAMASES; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; HUMANS;

EID: 11144291385     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.08.009     Document Type: Article

References (22)

1. C. De Champs, M.P. Sauvant, C. Chanal, D. Sirot, N. Gazuy, R. Malhuret, J.C. Baguet, and J. Sirot Prospective survey of colonization and infection caused by expanded-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit J. Clin. Microbiol. 27 1989 2887 2890
2. B. Du, Y. Long, H. Liu, D. Chen, D. Liu, Y. Xu, and X. Xie Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: Risk factors and clinical outcome Intensive Care Med. 28 2002 1718 1723
3. R.P. Hobson, F.M. MacKenzie, and I.M. Gould An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland J. Hosp. Infect. 33 1996 249 262
4. B.N. Kim, J.H. Woo, M.N. Kim, J. Ryu, and Y.S. Kim Clinical implications of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteraemia J. Hosp. Infect. 52 2002 99 106
5. Y.K. Kim, H. Pai, H.J. Lee, S.E. Park, E.H. Choi, J. Kim, J.H. Kim, and E.C. Kim Bloodstream infections by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in children: Epidemiology and clinical outcome Antimicrob. Agents Chemother. 46 2002 1481 1491
6. M. Kresken, D. Hafner, F.J. Schmitz, T.A. Wichelhaus für die Studiengruppe Resistenzsituation bei klinisch wichtigen Krankheitserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen & Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2001 2003 Antiinfectives Intelligence Bonn, Germany
7. E. Lautenbach, J.B. Patel, W.B. Bilker, P.H. Edelstein, and N.O. Fishman Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Risk factors for infection and impact of resistance on outcomes Clin. Infect. Dis. 32 2001 1162 1171
8. D.M. Livermore β-Lactamases in laboratory and clinical resistance Clin. Microbiol. Rev. 8 1995 557 584
9. D.M. Livermore, and D.F. Brown Detection of beta-lactamase-mediated resistance J. Antimicrob. Chemother. 48 Suppl. 1 2001 59 64
10. D.M. Livermore, T.G. Winstanley, and K.P. Shannon Interpretative reading: Recognizing the unusual and inferring resistance mechanisms from resistance phenotypes J. Antimicrob. Chemother. 48 2001 87 102
11. J.C. Lucet, S. Chevret, D. Decre, D. Vanjak, A. Macrez, J.P. Bedos, M. Wolff, and B. Regnier Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition Clin. Infect. Dis. 22 1996 430 436
12. J.C. Lucet, D. Decre, A. Fichelle, M.L. Joly-Guillou, M. Pernet, C. Deblangy, M.J. Kosmann, and B. Regnier Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital Clin. Infect. Dis. 29 1999 1411 1418
13. F.M. MacKenzie, C.A. Miller, and I.M. Gould Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection Clin. Microbiol. Infect. 8 2002 715 724
14. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing: Thirteenth informational supplement. MIC testing supplemental tables (NCCLS Document M100-S13) 2003 NCCLS Wayne, PA
15. D.L. Paterson Extended-spectrum beta-lactamases: The European experience Curr. Opin. Infect. Dis. 14 2001 697 701
16. D.L. Paterson, W.C. Ko, A. Von Gottberg, J.M. Casellas, L. Mulazimoglu, K.P. Klugman, R.A. Bonomo, L.B. Rice, J.G. McCormack, and V.L. Yu Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory J. Clin. Microbiol. 39 2001 2206 2212
17. C. Pena, M. Pujol, C. Ardanuy, A. Ricart, R. Pallares, J. Linares, J. Ariza, and F. Gudiol Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases Antimicrob. Agents Chemother. 42 1998 53 58
18. C.L. Pessoa-Silva, B. Meurer Moreira, V. Camara Almeida, B. Flannery, M.C. Almeida Lins, J.L. Mello Sampaio, L. Martins Teixeira, L.E. Vaz Miranda, L.W. Riley, and J.L. Gerberding Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit: Risk factors for infection and colonization J. Hosp. Infect. 53 2003 198 206
19. E. Stürenburg, A. Kühn, D. Mack, and R. Laufs A novel extended-spectrum beta-lactamase CTX-M-23 with a P167T substitution in the active-site omega loop associated with ceftazidime resistance J. Antimicrob. Chemother. 54 2004 406 409
20. E. Stürenburg, and D. Mack Extended-spectrum β-lactamases: Implications for the clinical microbiology laboratory J. Infect. 47 2003 273 295
21. E. Stürenburg, I. Sobottka, H.H. Feucht, D. Mack, and R. Laufs Comparison of BD Phoenix and VITEK2 automated antimicrobial susceptibility test systems for extended-spectrum beta-lactamase detection in Escherichia coli and Klebsiella species clinical isolates Diagn. Microbiol. Infect. Dis. 45 2003 29 34
22. E. Stürenburg, I. Sobottka, D. Noor, R. Laufs, and D. Mack Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum β-lactamases in an Enterobacteriaceae strain collection J. Antimicrob. Chemother. 54 2004 134 138